The Adequacy of Phosphorus Binder Prescriptions among American Hemodialysis Patients

REFERENCES

• KDOQI. NKF KDOQI guidelines. Available at: http://www.kidney.org/professionals/kdoqi/guidelines_bone/index.htm. Accessed July 2011.
   Google Scholar
• Gutie´rrez OM, Mannstadt M, Isakova T, . Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359(6):584–592.
   PubMed Web of Science ®Google Scholar
• Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis. 1998;31(4):607–617.
   PubMed Web of Science ®Google Scholar
• Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001;12(10):2131–2138.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kuwae N, Regidor DL, . Survival predictability of time varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70(4):771–780.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Benot A, Martin-Malo A, Alvarez-Lara MA, Rodriguez M, Aljama P. Mild hyperphosphatemia and mortality in hemodialysis patients. Am J Kidney Dis. 2005;46(1):68–77.
   PubMed Web of Science ®Google Scholar
• Tentori F, Blayney M, Albert J, . Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52(3):519–530.
   PubMed Web of Science ®Google Scholar
• Wald R, Sarnak M, Tighiouart H, . Disordered mineral metabolism in hemodialysis patients: Analysis of cumulative effects in the hemodialysis (HEMO) study. Am J Kidney Dis. 2008;52(3):531–540.
   PubMed Web of Science ®Google Scholar
• Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8): 2208–2218.
   PubMed Web of Science ®Google Scholar
• Ribeiro S, Ramos A, Brandao A, . Cardiac valve calcification in hemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant. 1998;13(8):2037–2040.
   PubMed Web of Science ®Google Scholar
• Goodman WG. The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Semin Dial. 2004;17(3):209–216.
   PubMed Web of Science ®Google Scholar
• Malluche HH, Mawad H. Management of hyperphosphatemia of chronic kidney disease: Lessons from the past and future directions. Nephrol Dial Transplant. 2002;17(7):1170–1175.
   PubMed Web of Science ®Google Scholar
• Young EW, Akiba T, Albert JM, . Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004;44(S2):S34–S38.
   PubMedGoogle Scholar
• Sullivan C, Sayre SS, Leon JB, . Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: A randomized controlled trial. J Am Med Assoc. 2009;301(6):629–635.
   PubMed Web of Science ®Google Scholar
• Ashurst I, Dip PG, Dobbie H. A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients. J Ren Nutr. 2003;13(4):267–274.
   PubMed Web of Science ®Google Scholar
• Mayne TJ, Benner D, Ricketts K, . Results of a pilot program to improve phosphorus outcomes in hemodialysis patients. [Published online ahead of print 2 November 2011]. J Ren Nutr. doi:10.1053/j.jrn.2011.08.006.
   Google Scholar
• Morey B, Walker R, Davenport A. More dietetic time, better outcome? Nephron Clin Pract. 2008;109:c173–c180.
   Google Scholar
• Data.Medicare.Gov. Dialysis facility compare – listing by facility. Available at: https://data.medicare.gov/dataset/Dialysis-Facility-Compare-Listing-by-Facility/23ew-n7w9. Accessed July 2011.
   Google Scholar
• Daugirdas JT, Finn WF, Emmett M, Chertow GM. The frequent hemodialysis network trial group. The phosphate binder equivalent dose. Semin Dial. 2011;24(1):41–49.
   PubMed Web of Science ®Google Scholar
• Uribarri J, Calvo MS. Hidden sources of phosphorus in the typical American diet: Does it matter in nephrology? Semin Dial. 2003;16(3):186–188.
   PubMed Web of Science ®Google Scholar
• Uribarri J. Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial. 2007;20(4):295–301.
   PubMed Web of Science ®Google Scholar
• Ramirez JA, Emmett M, White MG, . The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int. 1986;30:753–759.
   PubMed Web of Science ®Google Scholar
• Finn WF. Phosphorus management in end-stage renal disease. Semin Dial. 2005;18(1):8–12.
   PubMed Web of Science ®Google Scholar
• Kooienga L. Phosphorus balance with daily dialysis. Semin Dial. 2007;20(4):342–345.
   PubMed Web of Science ®Google Scholar
• Browner WS, Newman TB, Hulley SB. Estimating sample size and power: Applications and examples. In: Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB, eds. Designing Clinical Research. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2007:65–94.
   Google Scholar
• Kalantar-Zadeh K, Ikizler A, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis. 2003;42(5):864–881.
   PubMed Web of Science ®Google Scholar
• Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009;4(6):1089–1096.
   PubMed Web of Science ®Google Scholar
• Sprague SM, Abboud H, Qiu P, Dauphin M, Zhang P, Finn W. Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: A randomized trial. Clin J Am Soc Nephrol. 2009;4(1):178–185.
   PubMed Web of Science ®Google Scholar
• Finn W, Kingma-Johnson I. Urinary phosphorus excretion is a valuable measure of total body phosphorus burden in patients with CKD stages 3 and 4. J Am Soc Nephrol. 2008;19: 320A–321A.
   Google Scholar
• Burke SK, Slatopolsky EA, Goldberg DI. RenaGel, a novel calcium- and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers. Nephrol Dial Transplant. 1997;12:1640–1644.
   PubMed Web of Science ®Google Scholar
• Sullivan CM, Leon JB, Sehgal AS. Phosphorus-containing food additives and the accuracy of nutrient databases: Implications for renal patients. J Ren Nutr. 2007;17(5):350–354.
   PubMed Web of Science ®Google Scholar
• Sarathy S, Sullivan C, Leon JB, Sehgal AR. Fast food, phosphorus containing food additives, and the renal diet. J Ren Nutr. 2008;18(5):466–470.
   PubMed Web of Science ®Google Scholar
• Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: Implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8): 1370–1373.
   PubMed Web of Science ®Google Scholar
• Calvo MS. Dietary considerations to prevent loss of bone and renal function. Nutrition. 2000;16(7–8):564–566.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Gutekunst L, Mehrotra R, . Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:519–530.
   PubMed Web of Science ®Google Scholar
• PhosLo. Waltham, MA: Fresenius Medical Care; 2007.
   Google Scholar
• Renagel. Cambridge, MA: Genzyme Corporation; 2007.
   Google Scholar
• Renvela. Cambridge, MA: Genzyme Corporation; 2010.
   Google Scholar
• Fosrenol. Wayne, PA: Shire US Inc.; 2011.
   Google Scholar
• Murray L (ed.). Dosing information for dyspepsia products. In: PDR for Nonprescription Drugs, Dietary Supplements, and Herbs. Montvale, NJ: Thomson PDR; 2005:160.
   Google Scholar
• Benini O, D’Alessandro C, Gianfaldoni D, Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: A real and insidious danger for renal patients. J Ren Nutr. 2011;21(4):303–308.
   PubMed Web of Science ®Google Scholar
• Manley HJ, Garvin CG, Drayer DK, . Medication prescribing patterns in ambulatory hemodialysis patients: Comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant. 2004;19:1842–1848.
   PubMed Web of Science ®Google Scholar
• Karamanidou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008;9:2.
   PubMed Web of Science ®Google Scholar
• Schorr M, Manns BJ, Culleton B, . The effect of nocturnal and conventional hemodialysis on markers of nutritional status: Results from a randomized trial. J Ren Nutr. 2011;21(3):271–276.
   PubMed Web of Science ®Google Scholar
• Kjellstrand CM, Ing TS, Kjellstrand PT, Odar-Cederlof I, Lagg CR. Phosphorus dynamics during hemodialysis. Hemodial Int. 2011;15(2):226–233.
   PubMed Web of Science ®Google Scholar